Search Results - Michael Dymock

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    A practical guide to simulation for an adaptive trial design with a single interim analysis by Kaushala S. Jayawardana, Michael Dymock, Robert K. Mahar, Julie A. Marsh, Katherine J. Lee

    Published in Trials (2025-10-01)
    Get full text
    Article


  2. 2

    Statistical considerations for the platform trial in COVID-19 vaccine priming and boosting by Michael Dymock, Charlie McLeod, Peter Richmond, Tom Snelling, Julie A. Marsh, On behalf of the PICOBOO Investigator Team

    Published in Trials (2024-07-01)
    Get full text
    Article


  3. 3

    Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and design by Michael Dymock, James H. McMahon, David Griffin, Michelle Hagenauer, Tom L. Snelling, Julie A. Marsh, On behalf of the BOOST-IC Investigator Team

    Published in Trials (2025-07-01)
    Get full text
    Article


  4. 4

    Applying causal inference and Bayesian statistics to understanding vaccine safety signals using a simulation study by Evelyn Tay, Michael Dymock, Laura Lopez, Catherine Glover, Yuanfei Anny Huang, K. Shuvo Bakar, Thomas Snelling, Julie A. Marsh, Yue Wu

    Published in npj Vaccines (2024-09-01)
    Get full text
    Article


  5. 5

    Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in Australia by Thuy Nguyen, Lucy Dawes, Yuanfei Anny Huang, Evelyn Tay, Michael Dymock, Megan O'Moore, Clare King, Kristine Macartney, Nicholas Wood, Lucy Deng

    Get full text
    Article


  6. 6

    Short-Term Active Safety Surveillance of the Spikevax and Nuvaxovid Priming Doses in Australia by Renee Reynolds, Evelyn Tay, Michael Dymock, Lucy Deng, Catherine Glover, Laura K. Lopez, Yuanfei Anny Huang, Patrick Cashman, Alan Leeb, Julie A. Marsh, Tom Snelling, Nicholas Wood, Kristine Macartney

    Published in Vaccines (2024-08-01)
    Get full text
    Article


  7. 7

    Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial by David W. J. Griffin, Michael Dymock, Germaine Wong, C. Orla Morrissey, Sharon R. Lewin, Allen C. Cheng, Kirsten Howard, Julie A. Marsh, Kanta Subbarao, Michelle Hagenauer, Janine Roney, Anthony Cunningham, Tom Snelling, James H. McMahon

    Published in Trials (2024-07-01)
    Get full text
    Article


  8. 8

    Predicting the causative pathogen among children with pneumonia using a causal Bayesian network. by Yue Wu, Steven Mascaro, Mejbah Bhuiyan, Parveen Fathima, Ariel O Mace, Mark P Nicol, Peter C Richmond, Lea-Ann Kirkham, Michael Dymock, David A Foley, Charlie McLeod, Meredith L Borland, Andrew Martin, Phoebe C M Williams, Julie A Marsh, Thomas L Snelling, Christopher C Blyth

    Published in PLoS Computational Biology (2023-03-01)
    Get full text
    Article


  9. 9

    A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform tri... by Robert K. Mahar, Anna McGlothlin, Michael Dymock, Todd C. Lee, Roger J. Lewis, Thomas Lumley, Jocelyn Mora, David J. Price, Benjamin R. Saville, Tom Snelling, Rebecca Turner, Steven A. Webb, Joshua S. Davis, Steven Y. C. Tong, Julie A. Marsh, on behalf of the SNAP Global Trial Steering Committee

    Published in Trials (2023-12-01)
    Get full text
    Article


  10. 10

    Evaluating the impact of the ‘Blow, Breathe, Cough’ health promotion intervention in resolving otitis media with effusion in children: An adaptive randomized-controlled trial proto... by Jaimee R. Rich, Michael Dymock, Elke J. Seppanen, Elena Montgomery, Tanisha Cayley, Tamara Veselinović, Greta Bernabei, Anri Lester, Amy Hannigan, Nicole Irvine, Kerryn Gidgup, Edna Ninyette, Steph Bray, Tu Trang Tran, Valerie M. Swift, Melinda Edmunds, Natalie Strobel, Daniel McAullay, Julie Marsh, Evelyn Tay, Lea-Ann S. Kirkham, Ruth B. Thornton, Robyn S.M. Choi, Lydia Timms, Emily Jackson, Jafri Kuthubutheen, Peter C. Richmond, Christopher G. Brennan-Jones

    Get full text
    Article


  11. 11

    Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial by Robert K. Mahar, Anna McGlothlin, Michael Dymock, Lauren Barina, Marc Bonten, Asha Bowen, Matthew P. Cheng, Nick Daneman, Anna L. Goodman, Todd C. Lee, Roger J. Lewis, Thomas Lumley, Alistair R. D. McLean, Zoe McQuilten, Jocelyn Mora, David L. Paterson, David J. Price, Jason Roberts, Tom Snelling, Jonas Tverring, Steve A. Webb, Dafna Yahav, Joshua S. Davis, Steven Y. C. Tong, Julie A. Marsh, on behalf of the SNAP Global Trial Steering Committee

    Published in Trials (2025-02-01)
    Get full text
    Article


Search Tools: